ALPCO
@ALPCO
Followers
310
Following
170
Media
635
Statuses
2K
ALPCO offers a wide range of testing solutions, providing scientists and healthcare professionals with vital insights for advancing research and quality of care
Salem, NH, USA
Joined February 2011
From gastroenterology and infectious disease to endocrinology and allergy, ALPCO's innovative, walk-away, sample-to-answer platforms are designed to streamline your workflow and deliver accurate results. Take your diagnostics to the next level:
0
0
0
🌍 Today on World Allergy Day, we’re raising awareness about the impact of allergies and the importance of accurate, efficient diagnostics. Learn more:
0
0
1
Are your EPI diagnostics delivering the confidence your lab needs? ALPCO’s PE test detects both CELA3A and CELA3B isoforms to reduce false negatives and simplify diagnosis with a 200 µg/g cutoff. Clinically validated for better patient outcomes:
0
0
0
ALPCO’s Calprotectin Chemiluminescence ELISA delivers accuracy, affordability, and convenience for batch processing. ✔️ Sensitivity: 92%. ✔️ Specificity: 95%. ✔️ Range: 7.9–6,000 µg/g. ✔️ Compatible with most luminescence plate readers. Explore more:
0
1
1
Our office will be closed on Thursday, 7/3 and Friday, 7/4 in observance of the Independence Day. We wish everyone a safe and happy holiday weekend! 🇺🇸
0
0
0
We’re excited to be exhibiting at ADLM 2025 July 29-31!. Join us at booth #3245 to see how our automated diagnostic platforms are helping labs deliver faster, more reliable results in gastro and infectious disease. When accuracy counts, we’re here to support your lab’s success.
0
0
1
ALPCO’s new Human Growth Hormone (HGH) ELISA is now available for quantitative determination of growth hormone in serum! Our HGH ELISA offers high sensitivity down to 0.2 ng/mL. Enhance your research with precision—learn more today:
0
0
0
Early detection of EPI is key to preventing malnutrition & vitamin deficiencies. ALPCO offers FDA-registered manual and automated PE tests—non-invasive, accessible tools that support accurate diagnosis and better care. Learn moreI:
0
0
0
Friday’s Leadership Spotlight: Jim Richard, VP of Quality & Regulatory at ALPCO. With 30+ years in R&D, Operations & Quality, Jim leads our QMS & global regulatory strategy. A Master Black Belt who’s trained 1,000+ pros, Jim drives product excellence:
0
0
0
🌙Join us at SLRCH in Boston, June 13-16 at Simmons University!. Stop by our shared booth with NovoLytiX to learn about the new Melatonin ELISA, which showed strong correlation to the gold-standard RIA in a recent independent study. Learn more:
0
0
0
Take advantage of 25% off trial pricing on FGF23 (Intact) and FGF23 (C-Terminal) ELISA Kits, now available in the U.S. through ALPCO. 🔗
0
0
0
Timely IBD diagnosis is key to better outcomes in Crohn’s and colitis. Join Dr. @MaiaKayalMD on June 4 at 12 PM EST for a live ALPCO webinar on how primary care, emergency departments, and ACPs can help close the diagnostic gap. Register today:
0
1
1
🇺🇸 Memorial Day Closure Notice 🇺🇸. ALPCO’s offices will be closed on Monday, May 26. We remember and honor those who have made the ultimate sacrifice for our freedom. Wishing you a safe and meaningful Memorial Day.
0
0
0
ALPCO is proud to support the @CrohnsColitisFn’s Take Steps Walk! Join us Saturday, June 7 at 9AM at North Point Park in Cambridge to raise awareness & funds for those affected. Let’s take steps toward a cure💙
0
0
2
🧬Are your EPI diagnostics accurate enough? ALPCO’s fecal Pancreatic Elastase (PE) test detects both CELA3A & CELA3B isoforms to reduce under-reporting. One 200 µg/g cut-off simplifies diagnosis and supports better outcomes. Learn more:
0
0
0
IBD symptoms can be vague and lead to delayed diagnosis. Join Dr. @MaiaKayalMD on June 4 at 12 PM EST as he covers clinical signs, diagnostic markers & early intervention strategies. 🔗 Register:
0
0
0